SHEA Guidelines and Expert Guidance Documents

SHEA Expert Guidance Documents, Expert Consensus Statements, Guidelines, and White Papers are developed by panels of experts who review the available evidence, and apply their clinical experience and expertise to make practical recommendations. The process for development of the first three types of documents is described in the Handbook for SHEA-Sponsored Expert Guidance, Consensus, and Guideline Documents (pdf). The Handbook does not define the development process for white papers. The Handbook is reviewed and updated periodically by the SHEA Guidelines Committee, and updates are approved by the Board of Trustees.

  • Disinfection of Ultrasound Transducers Use for Percutaneous Procedures
    Current - Clinical Practice, Guidelines, Infection Prevention, Sterilization and Disinfection
    Author:
    ACEP, with AIUM, SHEA, APIC, AVA
    Published:
    February 1, 2021
    Abstract:

    This intersociety position statement addresses the issue of disinfection of transcutaneous ultrasound transducers used for percutaneous procedures or for monitoring other invasive procedures. Some organizations are not congruent in their recommendations for disinfection, with recommendations for high-level disinfection of sheathed probes for percutaneous procedures being not evidence-based and resulting in unwarranted and unnecessary use of resources, increase the possibility of safety events if procedures are performed without ultrasound guidance. This statement addresses several specific points for determining when to use high-level disinfection appropriately.

  • Disinfection and Sterilization of Prion-Contaminated Medical Instruments
    Current - Guidelines, Infection Prevention, Sterilization and Disinfection
    Author:
    SHEA
    Published:
    February 1, 2010
    Abstract:

    This SHEA guideline provides recommendations for disinfection and sterilization of medical instruments in order to prevent Creutzfeldt‐Jakob disease (CJD), a degenerative neurologic disorder caused by a proteinaceous infectious agent. Prion diseases elicit no immune response, result in a noninflammatory pathologic process confined to the central nervous system, have an incubation period of years, and usually are fatal within 1 year after diagnosis.

    Authors: Rutala WA, Weber DJ

    Reviewed: 2014

  • Infection Prevention and Control in the Long-Term Care Facility
    Current - Clinical Practice, Infection Prevention, Long-Term Care
    Author:
    APIC, SHEA
    Published:
    September 1, 2008
    Abstract:

    This SHEA/APIC guideline provides recommendations for prevention and control of infections in long-term care facilities, including UTIs, respiratory tract infections, skin and soft-tissue infections and infestations, gastrointestinal infections, infections caused by antibiotic-resistant organisms, and epidemic infections. It also reviews the structure and elements of infection control programs in the long-term care setting, regulatory considerations, education, and surveillance.

    Authors: Bratzler D, Dellinger EP, Olsen K, Perl T, Autwaerter P, Bolon M, Fish D, Napolitano L, Sawyer R, Slain D, Steinberg J, Weinstein R

  • Antimicrobial Prophylaxis in Surgery
    Current - Clinical Practice, Guidelines, Infection Prevention, Sterilization and Disinfection, Surgical Site Infections
    Author:
    ASHP, SHEA, IDSA, SIS
    Published:
    March 1, 2018
    Abstract:

    These ASHP, SHEA, IDSA, and SIS clinical practice guidelines provide practitioners with a standardized approach to the rational, safe, and effective use of antimicrobial agents for the prevention of surgical-site infections based on available clinical evidence and emerging issues.

    Authors: Bratzler D, Dellinger EP, Olsen K, Perl T, Autwaerter P, Bolon M, Fish D, Napolitano L, Sawyer R, Slain D, Steinberg J, Weinstein R

    Reviewed: 2/4/2013

  • Infection Prevention and Control Guideline for Cystic Fibrosis: 2013 Update
    Current - Clinical Practice, Guidelines, Immunocompromised Patients, Infection Prevention
    Author:
    Cystic Fibrosis Foundation, SHEA
    Published:
    August 1, 2018
    Abstract:

    This CFF and SHEA guideline updates the 2003 Cystic Fibrosis Foundation recommendations for infection prevention and control to reduce the risk of acquisition and transmission of pathogens among people with CF.

    Authors: Saiman L, Siegel JD, LiPuma JJ, Brown RF, Bryson EA, Chambers MJ, Downer VS, Fliege J, Hazle LA, Jain M, Marshall BC, O’Malley C, Pattee SR, Potter-Bynoe G, Reid S, Robinson KA, Sabadosa KA, Schmidt HJ, Tullis E, Webber J, Weber DJ

    Reviewed: 8/1/2014

  • Outbreak Response and Incident Management
    Current - Clinical Practice, Guidelines, Infection Prevention, Outbreak Investigation, Outbreak Response, Public Health
    Author:
    SHEA, cleared by CDC and endorsed by AACN, ACEP, CSTE, HCA Healthcare, IDSA, The Joint Commission, NACCHO, and PIDS
    Published:
    November 30, 2017
    Abstract:

    This SHEA expert guidance document, developed as part of the SHEA/CDC Outbreak Response Training Program (ORTP), provides recommendations for incident management during infectious diseases outbreaks and how to work within an emergency response framework. The guidance’s recommendations are not pathogen-specific and are meant to apply to a range of potential infectious diseases outbreaks.

    Authors: Banach DB, Johnston BL, Al-Zubeidi D, Bartlett AH, Bleasdale SC, Deloney VM, Enfield KB, Guzman-Cottrill JA, Lowe C, Ostrosky-Zeichner L, Popovich KJ, Patel PK, Ravin K, Rowe T, Shenoy ES, Stienecker R, Tosh PK, Trivedi KK

    Pocket Guide:
  • Duration of Contact Precautions for Acute-Care Settings
    Current - Clinical Practice, Guidelines, Infection Prevention, Patients, Quality Improvement
    Author:
    SHEA
    Published:
    January 11, 2018
    Abstract:

    This SHEA expert guidance advises hospitals in when they can safely discontinue contact precautions for patients with multidrug-resistant bacteria, addressing how long hospital staff should use these safety protocols to reduce the spread of pathogens within the hospital, in most cases ranging from one to three negative cultures prior to discontinuation. The guidance also outlines the use of molecular testing in care decisions.

    Authors: Banach DB, Bearman G, Barnden M, Hanrahan JA, Leekha S, Morgan DJ, Murthy R, Munoz-Price LS, Sullivan KV, Popovich KJ, Wiemken TL

  • Clinical Practice Guidelines for CDI in Adults and Children: 2017 Update
    Current - Antimicrobial Stewardship, C. difficile, Clinical Practice, Guidelines, Quality Improvement
    Author:
    IDSA and SHEA
    Published:
    February 22, 2018
    Abstract:

    IDSA and SHEA update to the 2010 clinical practice guideline on Clostridium difficile infection (CDI) in adults, incorporating recommendations for children (following the adult recommendations for epidemiology, diagnosis, and treatment) and significant changes in the management of CDI reflecting the evolving controversy over best methods for diagnosis. This evidence-based guideline updates recommendations regarding epidemiology, diagnosis, treatment, infection prevention, and environmental management.

    Authors: McDonald LC, Gerding D, Johnson S, Bakken J, Carroll K, Coffin S, Dubberke E, Garey K, Gould C, Kelly C, Loo V, Sammons JS, Sandora T, Wilcox M

    Partial Update: January 2021

  • NICU White Paper Series: Respiratory Infections
    Under Development - Clinical Practice
  • NICU White Paper Series: Practical approaches to C. difficile prevention
    Current - C. difficile, CLABSI, Clinical Practice, S. aureus
    Author:
    SHEA, endorsed by APIC, IDSA, The Joint Commission, NANN, PIDS, and VON
    Published:
    August 30, 2018
    Abstract:

    These white papers serve as companion to CDC’s Healthcare Infection Control Practices Advisory Committee (HICPAC) Recommendations for Prevention and Control of Infections in Neonatal Intensive Care Unit Patients and provide practical, expert opinion and/or evidence-based answers to frequently asked questions on infection detection and prevention in the NICU on S. aureusC. difficile, CLABSI, and respiratory infections.

    Authors: Sandora TJ, Bryant KK, Cantey JB, Elward AM, Yokoe DS, Bartlett AH

  • NICU White Paper Series: Practical approaches to S. aureus disease prevention
    Current - C. difficile, CLABSI, Clinical Practice, S. aureus
    Author:
    SHEA, endorsed by APIC, IDSA, The Joint Commission, NANN, PIDS, and VON
    Published:
    September 14, 2020
    Abstract:

    These white papers serve as companion to CDC’s Healthcare Infection Control Practices Advisory Committee (HICPAC) Recommendations for Prevention and Control of Infections in Neonatal Intensive Care Unit Patients and provide practical, expert opinion and/or evidence-based answers to frequently asked questions on infection detection and prevention in the NICU on S. aureusC. difficile, CLABSI, and respiratory infections.

    Authors: Akinboyo IC, Zangwill KM, Berg WM, Cantey JB, Huizinga B, Milstone AM

  • Infection Prevention in the Operating Room Anesthesia Work Area
    Current - CLABSI, Clinical Practice, Hand Hygiene, Infection Prevention, Surgical Site Infections
    Author:
    SHEA, endorsed by AAAA, AANA, AORN, and ASPF
    Published:
    December 11, 2018
    Abstract:

    This SHEA expert guidance gives infection prevention and control recommendations related to hand hygiene (activities, glove use, alcohol-based hand sanitizer), reusable versus single-use devices, environmental cleaning and management, use of injection ports, barrier precautions, and vials, syringes, and IV bags.

    Authors: Munoz-Price LS, Bowdle A, Johnston BL, Bearman G, Camins BC, Dellinger EP, Geisz-Everson MA, Holzmann-Pazgal G, Murthy R, Pegues D, Prielipp RC, Rubin ZA, Schaffzin J, Yokoe D, Birnbach DJ

We use cookies to help improve your experience
Ok